.Along with a triad of biotechs attacking the Nasdaq on Friday, it was very easy to overlook a small...
.Immune checkpoint preventions are the superheroes of cancer treatment. Drugs like Bristol Myers Squ...
.Invite to this week's Chutes & Ladders, our roundup of considerable management hirings, shooting...
.Regeneron is back along with long-lasting follow-up for its own LAG-3 inhibitor and PD-1 inhibitor ...
.AstraZeneca has discussed a very early check out the functionality of its own in-house antibody-dru...
.After revealing a phase 3 launch based on favorable midstage end results, iTeos and GSK are actuall...
.The FDA ought to be much more open as well as collaborative to let loose a rise in approvals of unc...
.It's an abnormally active Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara Rehab...
.Atea Pharmaceuticals' antiviral has actually fallen short an additional COVID-19 trial, however the...
.Neurocrine Biosciences' mental illness program pivot has stopped working. The biotech was unable to...